StocksMedium•4 November 2026•
1 min read
Arcutis Biotherapeutics Misses Q3 Earnings Estimates with $0.06 Per Share
Key Facts
1Arcutis Biotherapeutics reported Q3 earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.17 per share.
2The current quarter's earnings of $0.06 per share are identical to the earnings reported in the same period a year ago.
Arcutis Biotherapeutics reported earnings of $0.06 per share for the third quarter of 2026. Zacks reported that these results missed the consensus estimate of $0.17 per share.
The current quarter's earnings of $0.06 per share are identical to the earnings reported during the same period last year. ARQT closed at $32 on November 3, 2026, having reached a day high of $32.39 and a low of $31.27.